Literature DB >> 7538899

Does pregnancy immunize against breast cancer?

B Agrawal1, M A Reddish, M J Krantz, B M Longenecker.   

Abstract

Multiparity has been linked with protection against breast cancer. T cells from biparous women, but not T cells from nulliparous women or men, specifically proliferated in response to core peptide sequences of a human breast cancer-associated mucin (MUC-1). Two of the nulliparous women were retested during the first trimester of their first pregnancy, and their T cells proliferated specifically in response to MUC-1 mucin. These observations support the hypothesis that there is a natural immunization against MUC-1 peptide epitopes during pregnancy which provides some protection against the development of breast cancer. These data also suggest that certain MUC-1 synthetic peptides might be effective components of "vaccines" for therapy or prevention of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538899

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

3.  Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.

Authors:  Simone P Pinheiro; Susan E Hankinson; Shelley S Tworoger; Bernard A Rosner; John R McKolanis; Olivera J Finn; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

4.  Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.

Authors:  Brigitte Gückel; Christine Rentzsch; Maria-Dorothea Nastke; Alexander Marmé; Ines Gruber; Stefan Stevanović; Simone Kayser; Diethelm Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-22       Impact factor: 4.553

5.  Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.

Authors:  Jason A Dubovsky; Danielle L Chappell; Bonnie K Harrington; Kitty Agrawal; Leslie A Andritsos; Joseph M Flynn; Jeffrey A Jones; Michael E Paulaitis; Brad Bolon; Amy J Johnson; John C Byrd; Natarajan Muthusamy
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

6.  Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort.

Authors:  Daniel W Cramer; Raina N Fichorova; Kathryn L Terry; Hidemi Yamamoto; Allison F Vitonis; Eva Ardanaz; Dagfinn Aune; Heiner Boeing; Jenny Brändstedt; Marie-Christine Boutron-Ruault; Maria-Dolores Chirlaque; Miren Dorronsoro; Laure Dossus; Eric J Duell; Inger T Gram; Marc Gunter; Louise Hansen; Annika Idahl; Theron Johnson; Kay-Tee Khaw; Vittorio Krogh; Marina Kvaskoff; Amalia Mattiello; Giuseppe Matullo; Melissa A Merritt; Björn Nodin; Philippos Orfanos; N Charlotte Onland-Moret; Domenico Palli; Eleni Peppa; J Ramón Quirós; Maria-Jose Sánchez-Perez; Gianluca Severi; Anne Tjønneland; Ruth C Travis; Antonia Trichopoulou; Rosario Tumino; Elisabete Weiderpass; Renée T Fortner; Rudolf Kaaks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-04-16       Impact factor: 4.254

Review 7.  Tecemotide: an antigen-specific cancer immunotherapy.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael Wolf; Michael W DeGregorio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases.

Authors:  Mika Kamata; Kaori Denda-Nagai; Nobuyoshi Kubota; Satoshi Aida; Kazuyoshi Takeda; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine.

Authors:  Yefei Rong; Dayong Jin; Wenchuan Wu; Wenhui Lou; Danshong Wang; Tiantao Kuang; Xiaoling Ni; Xinyu Qin
Journal:  BMC Cancer       Date:  2009-06-18       Impact factor: 4.430

Review 10.  In-Vitro Fertilization Impact on the Risk of Breast Cancer: A Review Article.

Authors:  Dariush D Farhud; Shaghayegh Zokaei; Mohammad Keykhaei; Mehdi Hedayati; Marjan Zarif Yeganeh
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.